SLC5A2 and heart failure: Accordingly, this narrative review aims to synthesize the quantitative and qualitative lipid effects of SGLT2 inhibitors in patients with heart failure and to discuss their clinical implications, particularly as they relate to contemporary lipid-lowering strategies in this population.